These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36327298)

  • 1. Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans.
    Karoly HC; Prince MA; Emery NN; Smith EE; Piercey CJ; Conner BT
    PLoS One; 2022; 17(11):e0277123. PubMed ID: 36327298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products.
    Dowd AN; Zamarripa CA; Sholler DJ; Strickland JC; Goffi E; Borodovsky JT; Weerts EM; Vandrey R; Spindle TR
    Drug Alcohol Depend; 2023 Apr; 245():109826. PubMed ID: 36871378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use.
    Gibson LP; Gust CJ; Ellingson JM; YorkWilliams SL; Sempio C; Klawitter J; Bryan AD; Hutchison KE; Cinnamon Bidwell L
    Drug Alcohol Depend; 2021 Jun; 223():108718. PubMed ID: 33866072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates.
    Martin-Willett R; Skrzynski CJ; Karoly HC; Elmore JS; Bidwell LC
    Exp Clin Psychopharmacol; 2023 Dec; 31(6):1039-1049. PubMed ID: 37289543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
    Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE
    Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products.
    Gibson LP; Mueller RL; Winiger EA; Klawitter J; Sempio C; Williams S; Bryan AD; Bidwell LC; Hutchison KE
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):320-334. PubMed ID: 36378267
    [No Abstract]   [Full Text] [Related]  

  • 8. THC and CBD effects on alcohol use among alcohol and cannabis co-users.
    Karoly HC; Mueller RL; Andrade CC; Hutchison KE
    Psychol Addict Behav; 2021 Sep; 35(6):749-759. PubMed ID: 33764086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational models of cannabinoid vapor exposure in laboratory animals.
    Moore CF; Stiltner JW; Davis CM; Weerts EM
    Behav Pharmacol; 2022 Apr; 33(2&3):63-89. PubMed ID: 33136615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cannabinoids on resting state functional brain connectivity: A systematic review.
    Lorenzetti V; Gaillard A; Thomson D; Englund A; Freeman TP
    Neurosci Biobehav Rev; 2023 Feb; 145():105014. PubMed ID: 36563921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combining alcohol and cannabis on driving, breath alcohol level, blood THC, cognition, and subjective effects: A narrative review.
    Fares A; Wright M; Matheson J; Mann RE; Stoduto G; Le Foll B; Wickens CM; Brands B; Di Ciano P
    Exp Clin Psychopharmacol; 2022 Dec; 30(6):1036-1049. PubMed ID: 35049320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
    Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
    Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.
    Bidwell LC; Ellingson JM; Karoly HC; YorkWilliams SL; Hitchcock LN; Tracy BL; Klawitter J; Sempio C; Bryan AD; Hutchison KE
    JAMA Psychiatry; 2020 Aug; 77(8):787-796. PubMed ID: 32520316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial.
    Wickens CM; Wright M; Mann RE; Brands B; Di Ciano P; Stoduto G; Fares A; Matheson J; George TP; Rehm J; Shuper PA; Sproule B; Samohkvalov A; Huestis MA; Le Foll B
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Aug; 118():110570. PubMed ID: 35551928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of Δ
    Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Márquez F; Lozada M; Idaszkin YL; González-José R; Bigatti G
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):409-414. PubMed ID: 34061660
    [No Abstract]   [Full Text] [Related]  

  • 18. Advancing the science on cannabis concentrates and behavioural health.
    Bidwell LC; Martin-Willett R; Karoly HC
    Drug Alcohol Rev; 2021 Sep; 40(6):900-913. PubMed ID: 33783029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain.
    Cuttler C; LaFrance EM; Craft RM
    Cannabis Cannabinoid Res; 2022 Feb; 7(1):93-99. PubMed ID: 33998864
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
    Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV
    Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.